Tender For supply of torsemide 100 mg tab , torsemide 20mg tab , prucalopride 2 mg tab , chlordiazepoxide 5mg plus clidinium 25mg plus dicyclomine 10mg tab , terlipressin 1mg plus 10ml diluent or 010mg ml 10ml vial amp , polidocanol 3percent 2ml inj , ibandronate 150mg tab , inj carboprost tromethamine 250 mcg ml 1ml , tab clomifen citrate 50 mg , doxylamine succinate 10 mg usp plus pyridoxine hydrochloride 10 mg ip tab , misoprostol 100 mcg tab , levonorestrone 025 mg plus ethinyl estradiol 025mg pack of 20 tablets , methylergometrine maleate 02mg 1 ml inj , oxytocin 5 units per 1ml inj , magnesium sulphate 50 percent w v inj , gliclazide mr 30 mg tab , alendronate sodium 70 mg tab , thyroxine sodium 125 mcg tab , glycopyrrolate 02 mg ml 1ml inj , neostigmine 05 mg 1 ml inj , pyridostigmine 60 mg tab , succinylcholine chloride 50 mg ml 2 ml inj , vecuronium bromide 4mg ml 1 ml inj , tacrolimus 05 mg prolonged release cap , tacrolimus 1mg tab , sevelamer carbonate 400 mg tab , ciprofloxacin hcl 03percent tube of 5 gm , fluoresceine hydrochloride inj 20percent soln vial of 3ml , flurbiprofen sodium ophthalmic sol 003percent vial of 5 ml , gatifloxacin 03percent eye drop bott of 5 ml , e d homatropine hcl 2percent , e d brimonidine tartrate 02 percent , e d loteprednol etabonate 05percent bott of 5ml , lignocaine hydrochloride 4percent topical solution bott of 30 ml , carboxy methyl cellulose cmc 1percent gel , pilocarpine intracameral inj 05percent pilocarpine nitrate intra ocular inj without preservatives amp of 01ml each , prednisolone acetate 1percent w v eye drop bott of 5 ml , sodium chromoglycate eye drops 2percent bott of 5ml , e d sodium chloride 5percent bott 5ml hypersol , tobramycin 03percent eye drop bott of 5 ml , tropicamide 1percent plus phenylephrine 5percent eye drop bott of 5 ml , dorzolamide 2percent plus timolol 05percent bott of 5 ml e d , hyaluronidase 1500 iu inj 2 ml , diphenhydramine syp containing 10 15 mg 5 ml and ammonium chloride 100 150 mg sodium citrate 50 85 mg per 5 ml bott of 100 ml
Tender For re e-tender for procurement of drug items under table-a, for two years from the date of aoc - atazanavir 300mg + ritonavir 100 mg tabs, cephalexin oral suspension 250mg/5ml, conjugated estrogen 0.625mg tab, conjugated estrogen vaginal cream, estriol cream 0.1% w/w, dabigatran etexilate mesylate cap. 110 mg, delamanid 50mg tab., desmopressin nasal spray 100 mcg/ml, dicylomine hydrochloride 10 mg tab., fosphenytoin inj 50 mg/ml , 10 ml, glycopyrrolate inj.u.s.p. 0.2 mg / 1 ml amp., human recombinant growth hormone inj. iu [note: rate should be quoted per iu ], hydralazine inj 20 mg/ml, ibandronate 150 mg tab, ibandronate 50mg tab, imipramine tab. ip 25 mg, isoprenaline inj 2mg/1ml, leuprolide acetate inj.(3.75mg), norethistrone tab ip 5 mg, primaquine tab. i.p. 2.5 mg., primaquine tab.i.p. 7.5 mg., propofol inj.b.p. 1 %, w/v in 10 ml vial., rabies vaccines i.p. human use (cell culture derived) with minimum potency of 2.5 i.u/ vial for both id route & im route (one im dose or 5 id dose )+ diluents 0.5ml, ringers lactate inj.- glass bottle 500ml, sildenafil inj 10mg, sildenafil syrup 10mg/1 ml, snake anti venom serum i.p.liquid (10ml) neutralizing venoms of cobra, common krait, russells viper, saw scaled viper., sodium chloride inj 0.9% (normal or isotonic saline) glass bottle, sulphamethoxazole 100mg + trimethoprim 20mg tablet i.p, triptorelin 11.25 mg la inj, bupropion hydrochloride 150mg tab., carboplatin inj. 450 mg./ vial, haloperidol tab. 0.25mg, insulin (human pre mixed ) soluble & nph combination (30 : 70) or (25:75)/ i.u. -in vial(maximum pack size allowed 10ml /vial), insulin soluble inj. i.p.40 i.u. / ml in 10 ml vial ., nortriptyline 25mg tab., zinc sulphate 20 mg. (dispersable) tab., important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender.2. tendered quantity is just a tentative quantity and should not be treated as final. it may increase or decrease, as per need of the state. keeping this in mind, the supplier is not allowed to seek termination of the rate contract after finishing supply of tendered quantity.3. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period.4. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b) in case of sole manufacturer/importer (i.e. proprietary in nature).5. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis.6. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f(y), dated 07.06.2022 issued from finance department audit branch (group t).